CSBR
CSBR clinical trials: CHAMPIONS ONCOLOGY, INC.
Every trial on ClinicalTrials.gov where CHAMPIONS ONCOLOGY, INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 3
- Trials linked
- 1
- As lead sponsor
- 2
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
CSBR on the catalyst calendar · CSBR registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Nov 30, 2017Sponsor estimate | NCT02720796Patient-Derived Xenograft (PDX) Modeling in Adult Patients With Metastatic or Recurrent SarcomaChampions Oncology · Sarcoma | CSBRLead | No phase registered | Terminated | Locked | Locked | Locked |
| Jan 22, 2019Actual | NCT02247037Patient-derived Xenograft (PDX) Modeling of Treatment Response for Triple Negative Breast CancerIcahn School of Medicine at Mount Sinai · Triple Negative Breast Cancer | CSBRCollaborator | No phase registered | Completed | Locked | Locked | Locked |
| Oct 12, 2017Actual | NCT02752932TumorGraft- Guided Therapy for Improved Outcomes in Head and Neck Squamous Cell Cancer- A Feasibility StudyLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Head and Neck Squamous Cell Carcinoma | CSBRCollaborator | No phase registered | Completed | Locked | Locked | Locked |
- Primary completion Nov 30, 2017Sponsor estimateNo phase registeredNCT02720796Patient-Derived Xenograft (PDX) Modeling in Adult Patients With Metastatic or Recurrent SarcomaChampions Oncology · SarcomaTerminatedCSBRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 22, 2019ActualNo phase registeredNCT02247037Patient-derived Xenograft (PDX) Modeling of Treatment Response for Triple Negative Breast CancerIcahn School of Medicine at Mount Sinai · Triple Negative Breast CancerCompletedCSBRCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 12, 2017ActualNo phase registeredNCT02752932TumorGraft- Guided Therapy for Improved Outcomes in Head and Neck Squamous Cell Cancer- A Feasibility StudyLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Head and Neck Squamous Cell CarcinomaCompletedCSBRCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 3 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner